Global Nanopharmaceuticals Market Professional Survey Report 2017

  • KMI-168317
  • Sep 2017
  • 129 pages
  • Pharmaceutical
This report studies Nanopharmaceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion And Nanoemulsion
Nanosuspension

By Application, the market can be split into
Cancer
Tumor
Autoimmune Disorders

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.
Global Nanopharmaceuticals Market Professional Survey Report 2017
1 Industry Overview of Nanopharmaceuticals
1.1 Definition and Specifications of Nanopharmaceuticals
1.1.1 Definition of Nanopharmaceuticals
1.1.2 Specifications of Nanopharmaceuticals
1.2 Classification of Nanopharmaceuticals
1.2.1 Liposomes
1.2.2 Polymeric Micelles
1.2.3 Solid Lipid Nanoparticles
1.2.4 Microemulsion And Nanoemulsion
1.2.5 Nanosuspension
1.3 Applications of Nanopharmaceuticals
1.3.1 Cancer
1.3.2 Tumor
1.3.3 Autoimmune Disorders
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Nanopharmaceuticals
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nanopharmaceuticals
2.3 Manufacturing Process Analysis of Nanopharmaceuticals
2.4 Industry Chain Structure of Nanopharmaceuticals

3 Technical Data and Manufacturing Plants Analysis of Nanopharmaceuticals
3.1 Capacity and Commercial Production Date of Global Nanopharmaceuticals Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Nanopharmaceuticals Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Nanopharmaceuticals Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Nanopharmaceuticals Major Manufacturers in 2016

4 Global Nanopharmaceuticals Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Nanopharmaceuticals Capacity and Growth Rate Analysis
4.2.2 2016 Nanopharmaceuticals Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Nanopharmaceuticals Sales and Growth Rate Analysis
4.3.2 2016 Nanopharmaceuticals Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Nanopharmaceuticals Sales Price
4.4.2 2016 Nanopharmaceuticals Sales Price Analysis (Company Segment)

5 Nanopharmaceuticals Regional Market Analysis
5.1 North America Nanopharmaceuticals Market Analysis
5.1.1 North America Nanopharmaceuticals Market Overview
5.1.2 North America 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.1.4 North America 2016 Nanopharmaceuticals Market Share Analysis
5.2 China Nanopharmaceuticals Market Analysis
5.2.1 China Nanopharmaceuticals Market Overview
5.2.2 China 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.2.4 China 2016 Nanopharmaceuticals Market Share Analysis
5.3 Europe Nanopharmaceuticals Market Analysis
5.3.1 Europe Nanopharmaceuticals Market Overview
5.3.2 Europe 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.3.4 Europe 2016 Nanopharmaceuticals Market Share Analysis
5.4 Southeast Asia Nanopharmaceuticals Market Analysis
5.4.1 Southeast Asia Nanopharmaceuticals Market Overview
5.4.2 Southeast Asia 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.4.4 Southeast Asia 2016 Nanopharmaceuticals Market Share Analysis
5.5 Japan Nanopharmaceuticals Market Analysis
5.5.1 Japan Nanopharmaceuticals Market Overview
5.5.2 Japan 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.5.4 Japan 2016 Nanopharmaceuticals Market Share Analysis
5.6 India Nanopharmaceuticals Market Analysis
5.6.1 India Nanopharmaceuticals Market Overview
5.6.2 India 2012-2017E Nanopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Nanopharmaceuticals Sales Price Analysis
5.6.4 India 2016 Nanopharmaceuticals Market Share Analysis

6 Global 2012-2017E Nanopharmaceuticals Segment Market Analysis (by Type)
6.1 Global 2012-2017E Nanopharmaceuticals Sales by Type
6.2 Different Types of Nanopharmaceuticals Product Interview Price Analysis
6.3 Different Types of Nanopharmaceuticals Product Driving Factors Analysis
6.3.1 Liposomes of Nanopharmaceuticals Growth Driving Factor Analysis
6.3.2 Polymeric Micelles of Nanopharmaceuticals Growth Driving Factor Analysis
6.3.3 Solid Lipid Nanoparticles of Nanopharmaceuticals Growth Driving Factor Analysis
6.3.4 Microemulsion And Nanoemulsion of Nanopharmaceuticals Growth Driving Factor Analysis
6.3.5 Nanosuspension of Nanopharmaceuticals Growth Driving Factor Analysis

7 Global 2012-2017E Nanopharmaceuticals Segment Market Analysis (by Application)
7.1 Global 2012-2017E Nanopharmaceuticals Consumption by Application
7.2 Different Application of Nanopharmaceuticals Product Interview Price Analysis
7.3 Different Application of Nanopharmaceuticals Product Driving Factors Analysis
7.3.1 Cancer of Nanopharmaceuticals Growth Driving Factor Analysis
7.3.2 Tumor of Nanopharmaceuticals Growth Driving Factor Analysis
7.3.3 Autoimmune Disorders of Nanopharmaceuticals Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Nanopharmaceuticals
8.1 Merck
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Merck 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.2 Pfizer
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Pfizer 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Pfizer 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Novartis 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.4 Abbott
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Abbott 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Abbott 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.5 GlaxoSmithKline
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 GlaxoSmithKline 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GlaxoSmithKline 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.6 Roche
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Roche 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Roche 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.7 Sanofi
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Sanofi 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sanofi 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.8 Eli Lilly
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Eli Lilly 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Eli Lilly 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.9 Astrazeneca
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Astrazeneca 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Astrazeneca 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.10 Johnson & Johnson
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Johnson & Johnson 2016 Nanopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Johnson & Johnson 2016 Nanopharmaceuticals Business Region Distribution Analysis
8.11 Celgene
8.12 Novavax
8.13 Stryker
8.14 Gilead Sciences
8.15 OSI Pharmaceuticals
8.16 Kadmon Pharmaceuticals
8.17 Samyang Biopharm
8.18 Mitsubishi Pharma
8.19 Kaken Pharmaceutical
8.20 Selecta Biosciences
8.21 Par Pharmaceutical
8.22 Cerulean Pharma
8.23 Navidea Biopharmaceuticals
8.24 Lummy

9 Development Trend of Analysis of Nanopharmaceuticals Market
9.1 Global Nanopharmaceuticals Market Trend Analysis
9.1.1 Global 2017-2022 Nanopharmaceuticals Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Nanopharmaceuticals Sales Price Forecast
9.2 Nanopharmaceuticals Regional Market Trend
9.2.1 North America 2017-2022 Nanopharmaceuticals Consumption Forecast
9.2.2 China 2017-2022 Nanopharmaceuticals Consumption Forecast
9.2.3 Europe 2017-2022 Nanopharmaceuticals Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Nanopharmaceuticals Consumption Forecast
9.2.5 Japan 2017-2022 Nanopharmaceuticals Consumption Forecast
9.2.6 India 2017-2022 Nanopharmaceuticals Consumption Forecast
9.3 Nanopharmaceuticals Market Trend (Product Type)
9.4 Nanopharmaceuticals Market Trend (Application)

10 Nanopharmaceuticals Marketing Type Analysis
10.1 Nanopharmaceuticals Regional Marketing Type Analysis
10.2 Nanopharmaceuticals International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Nanopharmaceuticals by Region
10.4 Nanopharmaceuticals Supply Chain Analysis

11 Consumers Analysis of Nanopharmaceuticals
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Nanopharmaceuticals Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


List of Tables and Figures
Figure Picture of Nanopharmaceuticals
Table Product Specifications of Nanopharmaceuticals
Table Classification of Nanopharmaceuticals
Figure Global Production Market Share of Nanopharmaceuticals by Type in 2016
Figure Liposomes Picture
Table Major Manufacturers of Liposomes
Figure Polymeric Micelles Picture
Table Major Manufacturers of Polymeric Micelles
Figure Solid Lipid Nanoparticles Picture
Table Major Manufacturers of Solid Lipid Nanoparticles
Figure Microemulsion And Nanoemulsion Picture
Table Major Manufacturers of Microemulsion And Nanoemulsion
Figure Nanosuspension Picture
Table Major Manufacturers of Nanosuspension
Table Applications of Nanopharmaceuticals
Figure Global Consumption Volume Market Share of Nanopharmaceuticals by Application in 2016
Figure Cancer Examples
Table Major Consumers in Cancer
Figure Tumor Examples
Table Major Consumers in Tumor
Figure Autoimmune Disorders Examples
Table Major Consumers in Autoimmune Disorders
Figure Market Share of Nanopharmaceuticals by Regions
Figure North America Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Figure China Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Europe Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Southeast Asia Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Japan Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Figure India Nanopharmaceuticals Market Size (Million USD) (2012-2022)
Table Nanopharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nanopharmaceuticals in 2016
Figure Manufacturing Process Analysis of Nanopharmaceuticals
Figure Industry Chain Structure of Nanopharmaceuticals
Table Capacity and Commercial Production Date of Global Nanopharmaceuticals Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Nanopharmaceuticals Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Nanopharmaceuticals Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Nanopharmaceuticals Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Nanopharmaceuticals 2012-2017
Figure Global 2012-2017E Nanopharmaceuticals Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Nanopharmaceuticals Market Size (Value) and Growth Rate
Table 2012-2017E Global Nanopharmaceuticals Capacity and Growth Rate
Table 2016 Global Nanopharmaceuticals Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Nanopharmaceuticals Sales (K Units) and Growth Rate
Table 2016 Global Nanopharmaceuticals Sales (K Units) List (Company Segment)
Table 2012-2017E Global Nanopharmaceuticals Sales Price (USD/Unit)
Table 2016 Global Nanopharmaceuticals Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure North America 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure North America 2016 Nanopharmaceuticals Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure China 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure China 2016 Nanopharmaceuticals Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure Europe 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure Europe 2016 Nanopharmaceuticals Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure Southeast Asia 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure Southeast Asia 2016 Nanopharmaceuticals Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure Japan 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure Japan 2016 Nanopharmaceuticals Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Nanopharmaceuticals 2012-2017E
Figure India 2012-2017E Nanopharmaceuticals Sales Price (USD/Unit)
Figure India 2016 Nanopharmaceuticals Sales Market Share
Table Global 2012-2017E Nanopharmaceuticals Sales (K Units) by Type
Table Different Types Nanopharmaceuticals Product Interview Price
Table Global 2012-2017E Nanopharmaceuticals Sales (K Units) by Application
Table Different Application Nanopharmaceuticals Product Interview Price
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Nanopharmaceuticals Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Nanopharmaceuticals Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Nanopharmaceuticals Business Region Distribution
Table Abbott Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Nanopharmaceuticals Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Nanopharmaceuticals Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Nanopharmaceuticals Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Nanopharmaceuticals Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly Nanopharmaceuticals Business Region Distribution
Table Astrazeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astrazeneca Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Astrazeneca Nanopharmaceuticals Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Nanopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Nanopharmaceuticals Business Region Distribution
Table Celgene Information List
Table Novavax Information List
Table Stryker Information List
Table Gilead Sciences Information List
Table OSI Pharmaceuticals Information List
Table Kadmon Pharmaceuticals Information List
Table Samyang Biopharm Information List
Table Mitsubishi Pharma Information List
Table Kaken Pharmaceutical Information List
Table Selecta Biosciences Information List
Table Par Pharmaceutical Information List
Table Cerulean Pharma Information List
Table Navidea Biopharmaceuticals Information List
Table Lummy Information List
Figure Global 2017-2022 Nanopharmaceuticals Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Nanopharmaceuticals Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Nanopharmaceuticals Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Nanopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Nanopharmaceuticals by Type 2017-2022
Table Global Consumption Volume (K Units) of Nanopharmaceuticals by Application 2017-2022
Table Traders or Distributors with Contact Information of Nanopharmaceuticals by Region

Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Head-Sales
mansing
Mansingh Surve
Manager-Sales
Vivek
Vivek Pandey
Assistant Manager-Sales
Roshnee
Roshnee Tendulkar
Team Lead-Sales
view